OncoHost is a commercial-stage precision oncology company headquartered in Binyamina, Israel, and Cary, NC. Led by an experienced team of entrepreneurs and industry experts, and supported by a large-scale prospective clinical trial with over 35 sites worldwide, OncoHost aims to understand the patient's unique response to therapy to overcome one of the major obstacles in clinical oncology today – resistance to treatment. Supported by robust clinical evidence, strong IP positioning, and first-mover advantage, OncoHost has developed the PROphet® platform to guide earlier and more informed decision-making in the planning and management of individual patients' therapeutic journeys.